-
Signature
-
Chris Agbe-Davies as Attorney-in-Fact
-
Issuer symbol
-
PFG
-
Transactions as of
-
10 Dec 2025
-
Net transactions value
-
-$462,110
-
Form type
-
4
-
Filing time
-
11 Dec 2025, 17:06:06 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| McCullum Kenneth A. |
EVP - Chief Risk Officer |
711 HIGH STREET, DES MOINES |
Chris Agbe-Davies as Attorney-in-Fact |
11 Dec 2025 |
0001830834 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PFG |
Common Stock |
Award |
$322,061 |
+5,130 |
+13% |
$62.78 |
45,707 |
10 Dec 2025 |
Direct |
F1 |
| transaction |
PFG |
Common Stock |
Disposed to Issuer |
$462,110 |
-5,130 |
-11% |
$90.08 |
40,577 |
10 Dec 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PFG |
Common Stock |
Options Exercise |
$107,354 |
-1,710 |
-33% |
$62.78 |
3,420 |
10 Dec 2025 |
Common Stock |
1,710 |
$62.78 |
Direct |
|
| transaction |
PFG |
Common Stock |
Options Exercise |
$107,354 |
-1,710 |
-50% |
$62.78 |
1,710 |
10 Dec 2025 |
Common Stock |
1,710 |
$62.78 |
Direct |
|
| transaction |
PFG |
Common Stock |
Options Exercise |
$107,354 |
-1,710 |
-100% |
$62.78 |
0 |
10 Dec 2025 |
Common Stock |
1,710 |
$62.78 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: